Clinical and Translational Medicine (May 2022)

Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy

  • Lin Yin,
  • Na Li,
  • Weihua Jia,
  • Nuoqi Wang,
  • Meidai Liang,
  • Jiamin Shang,
  • Guifen Qiang,
  • Guanhua Du,
  • Xiuying Yang

DOI
https://doi.org/10.1002/ctm2.879
Journal volume & issue
Vol. 12, no. 5
pp. n/a – n/a

Abstract

Read online

No abstracts available.